Cargando…
A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan
Vaccinations are the main tool being used to control the COVID-19 pandemic. When the Japanese Ministry of Health approved the Moderna mRNA-1273 vaccination in May 2021, it was limited to patients over 18 years old; however, using the additional data of efficacy and safety from clinical trials, vacci...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japanese College of Cardiology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040371/ https://www.ncbi.nlm.nih.gov/pubmed/35495897 http://dx.doi.org/10.1016/j.jccase.2022.03.012 |